Skip to main content

Month: February 2023

Jeffersonville Bancorp Announces Fourth Quarter Earnings of $2,803,000 or $0.66 per share and Year to Date Earnings of $9,304,000 or $2.20 per share; Declares Dividend of $0.15

JEFFERSONVILLE, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) — Jeffersonville Bancorp, Inc. (OTCQB – JFBC) announced today fourth quarter net income of $2,803,000 or $0.66 per share compared to $1,442,000 or $0.34 per share for the same quarter in 2021. The increase in quarterly net income compared to 2021 of $1,361,000 was primarily attributable to an increase in loan interest and fees of $944,000, other interest and dividends of $723,000, and securities income of $671,000, partially offset by a decrease in net gain on sale of securities of $514,000, an increase in tax expense of $415,000, and an increase in non-interest expense of $139,000. Year to date net income as of December 31, 2022 was $9,304,000 or $2.20 per share compared to $5,944,000 or $1.40 per share for the same period in 2021. The increase in year-to-date net income...

Continue reading

Conduent Reports Fourth Quarter and Full Year 2022 Financial Results

Key Q4 and Full Year 2022 HighlightsResults continue to be consistent with expectations despite the economic uncertainty Revenue: Q4 $986M / FY $3,858M Adj. Revenue(1): Q4 $986M / FY $3,851M Pre-tax Income: Q4 $(365)M / FY $(127)M, impacted by a goodwill impairment charge of $358M Adj. EBITDA Margin(1): Q4 9.6% / FY 10.2% New business signings ACV(2): Q4 $194M / FY $732M Net ARR Activity Metric(2) (TTM): Q4 $114MFLORHAM PARK, N. J., Feb. 14, 2023 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions company, today announced its fourth quarter and full year 2022 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q4 and 2022 brought with it a mixture of both headwinds and tailwinds such as foreign exchange rates, inflation-induced volume degradation,...

Continue reading

Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook

Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP revenues of $97.9 million and core product and service revenues of $94.5 million Improved operating discipline and restructuring initiatives contributed to a 16% sequential decrease in operating expenses in the fourth quarter; Product and services margin improved sequentially by 620 basis points on a GAAP basis, 520 basis points on a non-GAAP basis Releasing 2023 guidance of flat to moderate growth in core product and service revenues, inclusive of previously disclosed transitory Genomics headwind; Expect 1,100–1,400 basis point GAAP gross margin expansion in the fourth quarter compared to fourth quarter of 2022 and approximately 20% reduction in operating expenses on a GAAP and non-GAAP...

Continue reading

Devon Energy Reports Fourth-Quarter and Full-Year 2022 Results; Declares Quarterly Dividend and Raises Fixed Dividend by 11 Percent in 2023

OKLAHOMA CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today reported financial and operational results for the fourth-quarter and full year 2022. The company also declared its quarterly dividend. Devon’s earnings release, supplemental financial tables, guidance and related earnings presentation can be accessed via the Investor Relations section of Devon’s website, www.devonenergy.com. The company’s fourth-quarter conference call will be held at 10:00 a.m. Central (11:00 a.m. Eastern) on Wednesday, February 15, 2023, and will serve primarily as a forum for analyst and investor questions and answers. ABOUT DEVON ENERGY Devon Energy is a leading oil and gas producer in the U.S. with a premier multi-basin portfolio headlined by a world-class acreage position in the Delaware Basin. Devon’s disciplined cash-return...

Continue reading

Udemy Reports Fourth Quarter and Full Year 2022 Results

Total revenue increased 22% year-over-year for both the fourth quarter and full yearAnnounced strategic actions to further accelerate path to profitability SAN FRANCISCO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today reported results for the three- and twelve-month periods ended December 31, 2022. “Udemy ended its first full year as a public company strong, despite a very challenging macro environment,” said Gregg Coccari, Udemy’s Chairman and CEO. “We continue to be encouraged by the strength of our leading growth engine, Udemy Business, which is supported by an accelerating shift from offline to online skills development, and the health of our Consumer marketplace. We are cautiously optimistic about the year ahead as we focus on balancing long-term sustainable...

Continue reading

iPower Reports Fiscal Second Quarter 2023 Results

– Fiscal Q2 Revenue up 12% to 19.3 Million – – iPower Management to Host Conference Call Today at 4:30 p.m. Eastern Time – DUARTE, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq:IPW) (“iPower” or the “Company”), a leading online retailer and supplier of consumer home and garden products, today announced financial results for its fiscal second quarter ended December 31, 2022. Fiscal Q2 2023 Results vs. Year-Ago Quarter (unless otherwise noted) Total revenue increased 12% to $19.3 million. Gross profit increased 5% to $8.0 million, with gross margin of 41.4% compared to 44.1%. Net loss attributable to iPower was $3.3 million or $(0.11) per share, compared to net income of $0.8 million or $0.03 per share. As of December 31, 2022, net debt (total debt less cash) was reduced by 42% to $8.2 million...

Continue reading

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results

SEATTLE, Feb. 14, 2023 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2022. “We finished the year with 20% revenue growth, driven by both our MRD and Immune Medicine business areas,” said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. “2023 has started strong and I am encouraged to see how momentum is building. We are growing revenue, advancing our pipeline and managing operating expenses with the capital to fuel sustainable growth and execute towards our goals.” Recent HighlightsRevenue of $55.2...

Continue reading

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

InteliSwab® revenue of $88.9 million in Q4, up 12% sequentially; wins two new federal government contracts extending the tail on InteliSwab® revenue Signs a deal with Quest Diagnostics Genomic Sequencing Services for saliva collection kits Q4 GAAP EPS of $0.21; Non-GAAP EPS of $0.36 Announces restructuring expected to result in operating expense savings of $15 million to be fully implemented by June 2023; targets achieving cash flow breakeven for core business by end of 2024 Cash balance grows to $111 million, up $9 million from prior quarter Management to Host Analyst/Investor Call and Webcast Today at 5:00 p.m. ET BETHLEHEM, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...

Continue reading

Safe Bulkers, Inc. Reports Fourth Quarter and Twelve Months 2022 Results and Declares Dividend on Common Stock

MONACO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three and twelve month periods ended December 31, 2022. The Board of Directors of the Company also declared a cash dividend of $0.05 per share of outstanding common stock.Financial highlights            In million U.S. Dollars except per share data Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Twelve Months 2022 Twelve Months 2021Net revenues 86.7 93.7 91.6 77.7 92.4 349.7 329.0Net income 34.9 51.0 50.3 36.4 65.2 172.6 174.3Adjusted net income1 37.0 48.8 50.4 32.3 50.4 168.5 154.0EBITDA2 53.8 69.1 66.5 51.0 82.4 240.4 244.3Adjusted EBITDA2 56.0 66.9 66.5 46.9 67.6 236.4 223.9Earnings per share basic and...

Continue reading

eGain Reports Record Revenue in Second Quarter of Fiscal 2023

SUNNYVALE, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — eGain (Nasdaq: EGAN), a leading knowledge platform for customer engagement automation, today announced financial results for its fiscal 2023 second quarter ended December 31, 2022. “We delivered another quarter of record revenue, ahead of our guidance and consensus estimates, and generated over $7 million in cash from operations,” said Ashu Roy, eGain’s CEO. “While sales cycles continue to lengthen in the current environment, market interest in knowledge-powered customer engagement remains high.” “Last week, we announced eGain Instant Answers™, a radically simple experience powered by Generative AI technology for knowledge users. Exciting innovation like this position us well as business conditions improve.” Fiscal 2023 Second Quarter Financial HighlightsTotal revenue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.